
(AGENPARL) – BRUXELLES mar 23 maggio 2023 The European Union has been regulating pharmaceuticals for over 50 years. The legal regulation aims to protect public health and ensure the proper functioning of the internal market in medicinal products. In 2020, the European Commission published a pharmaceutical strategy for Europe aimed at reinforcing the EU pharmaceutical system by making it more patient-centred and resistant to crises (such as pandemics). The achievement of these objectives requires the revision of several pieces of EU legislation regulating pharmaceuticals, including the EU general pharmaceutical legislation (Directive 2001/83/EC and Regulation (EC) No 726/2004). This briefing informs parliamentary decision-making by presenting findings on the implementation of the EU legislation falling within the scope of the revision.
Fonte : © Unione europea, 2023 – PE
Fonte/Source: https://www.europarl.europa.eu/thinktank/it/document/EPRS_BRI(2023)747422